Skip to content

Facilitating Implementation of Research Evidence

Facilitating Implementation of Research Evidence: a pragmatic randomised controlled trial with integral qualitative, quantitative and health economic evaluative components

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN11598502
Enrollment
1200
Registered
2010-03-16
Start date
2010-03-01
Completion date
Unknown
Last updated
2019-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Long-term nursing care Not Applicable Nursing care

Interventions

Arm 1: guidelines on continence care and an implementation guide (control) Arm 2: guidelines on continence care and an implementation guide and type A facilitation (a 12-month developm

Sponsors

University of Warwick (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Long-term nursing care settings with at least 60 places 2. Publically funded places 3. Residents who are aged 60 years or older 4. Interested in taking part in the study 5. Residents with documented urinary incontinence 6. Participants within each site will include those who have consented to be involved as: 6.1. Facilitators engaged in intervention delivery 6.2. Staff at all levels working in sites delivering care 6.3. Key stakeholders related to sites (e.g. regional administrators, funding agencies) 6.4. Residents and carers

Exclusion criteria

Exclusion criteria: Patients with moderate or severe dementia

Design outcomes

Secondary

MeasureTime frame
Clinical outcomes including: 1. Quality of life 2. Continence status 3. Pad use 4. Health economic analysis Follow up of outcome data is at 6, 12, 18 and 24 months after the interventions starts in all arms. Process data is also collected thoughout the study.

Primary

MeasureTime frame
The extent to which the guidelines are implemented, using clear criteria linked to the guidelines. Follow up of outcome data is at 6, 12, 18 and 24 months after the interventions starts in all arms. Process data is also collected thoughout the study.

Countries

Ireland, Netherlands, Sweden, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 26, 2026